Gelteq (GELS) Closes $5.2M IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- Anthropic logged net loss of over $80 billion in first half of 2026
- Xpeng shares climb as licensing model gains focus
Gelteq Limited Closes US$5.2 Million Initial Public Offering
October 30, 2024 10:00 AM EDTNEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (Gelteq or the Company), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The ordinary shares commenced trading on the Nasdaq Global Market on October 29, 2024 under the symbol GELS.
The gross proceeds from the offering, before deducting underwriting fees and other offering expenses payable by the Company, were US$5.2 million. The Company intends to use the net proceeds from the... More



